Cargando…

High mortality due to cutaneous melanoma in Norway: a study of prognostic factors in a nationwide cancer registry

PURPOSE: The purpose of this study was to examine why Norway has the highest rate of mortality due to cutaneous melanoma (CM) in Europe. The Norwegian Malignant Melanoma Registry (NMMR) enables the study of clinical and histopathological characteristics of patients who die due to CM. RESULTS: The NM...

Descripción completa

Detalles Bibliográficos
Autores principales: Robsahm, Trude Eid, Helsing, Per, Nilssen, Yngvar, Vos, Linda, Rizvi, Syed Mohammad H, Akslen, Lars A, Veierød, Marit B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5951132/
https://www.ncbi.nlm.nih.gov/pubmed/29780262
http://dx.doi.org/10.2147/CLEP.S151246
_version_ 1783322983435075584
author Robsahm, Trude Eid
Helsing, Per
Nilssen, Yngvar
Vos, Linda
Rizvi, Syed Mohammad H
Akslen, Lars A
Veierød, Marit B
author_facet Robsahm, Trude Eid
Helsing, Per
Nilssen, Yngvar
Vos, Linda
Rizvi, Syed Mohammad H
Akslen, Lars A
Veierød, Marit B
author_sort Robsahm, Trude Eid
collection PubMed
description PURPOSE: The purpose of this study was to examine why Norway has the highest rate of mortality due to cutaneous melanoma (CM) in Europe. The Norwegian Malignant Melanoma Registry (NMMR) enables the study of clinical and histopathological characteristics of patients who die due to CM. RESULTS: The NMMR and the Norwegian Cause of Death Registry provided data on the clinical and histopathological factors as well as the date and cause of death, through June 2015 for all first invasive CMs diagnosed in 2008–2012 (n=8087). Cox regression was used to estimate associations between clinical and pathological factors and CM-specific death. Multiple imputation was used to handle missing data. RESULTS: The CMs were equally distributed between men (49.9%) and women (50.1%), and the median follow-up was 4.0 years (range: 0.08–7.5 years). Trunk was the most common anatomic site (48%), superficial spreading melanoma was the dominant melanoma subtype (68.2%), median Breslow thickness was 1.0 mm, ulceration was present in 23% of CMs, and 91.8% of cases were in a local clinical stage at diagnosis. Compared to women, men were diagnosed at a higher age, with thicker and more-often-ulcerated tumor, and more often were in advanced clinical stages. During follow-up, 1015 patients died due to CM, representing 52.8% of all deaths. The nodular subtype made up the dominant proportion of fatal CM cases (55.3% in women, 64.6% in men). Sex, age, anatomic site (trunk), T-stage, ulceration, clinical stage, and having a second primary CM were associated with increased risk of CM-specific death. CONCLUSION: Our data suggest that the high rate of mortality due to CM observed in Norway is attributable to the more advanced stage of the disease at diagnosis. Most high-risk cases occurred in male patients ≥70 years of age. Efforts to improve awareness and secondary prevention of CM, including warning signs of all melanoma subtypes, are required urgently and should be targeted toward men in particular.
format Online
Article
Text
id pubmed-5951132
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-59511322018-05-18 High mortality due to cutaneous melanoma in Norway: a study of prognostic factors in a nationwide cancer registry Robsahm, Trude Eid Helsing, Per Nilssen, Yngvar Vos, Linda Rizvi, Syed Mohammad H Akslen, Lars A Veierød, Marit B Clin Epidemiol Original Research PURPOSE: The purpose of this study was to examine why Norway has the highest rate of mortality due to cutaneous melanoma (CM) in Europe. The Norwegian Malignant Melanoma Registry (NMMR) enables the study of clinical and histopathological characteristics of patients who die due to CM. RESULTS: The NMMR and the Norwegian Cause of Death Registry provided data on the clinical and histopathological factors as well as the date and cause of death, through June 2015 for all first invasive CMs diagnosed in 2008–2012 (n=8087). Cox regression was used to estimate associations between clinical and pathological factors and CM-specific death. Multiple imputation was used to handle missing data. RESULTS: The CMs were equally distributed between men (49.9%) and women (50.1%), and the median follow-up was 4.0 years (range: 0.08–7.5 years). Trunk was the most common anatomic site (48%), superficial spreading melanoma was the dominant melanoma subtype (68.2%), median Breslow thickness was 1.0 mm, ulceration was present in 23% of CMs, and 91.8% of cases were in a local clinical stage at diagnosis. Compared to women, men were diagnosed at a higher age, with thicker and more-often-ulcerated tumor, and more often were in advanced clinical stages. During follow-up, 1015 patients died due to CM, representing 52.8% of all deaths. The nodular subtype made up the dominant proportion of fatal CM cases (55.3% in women, 64.6% in men). Sex, age, anatomic site (trunk), T-stage, ulceration, clinical stage, and having a second primary CM were associated with increased risk of CM-specific death. CONCLUSION: Our data suggest that the high rate of mortality due to CM observed in Norway is attributable to the more advanced stage of the disease at diagnosis. Most high-risk cases occurred in male patients ≥70 years of age. Efforts to improve awareness and secondary prevention of CM, including warning signs of all melanoma subtypes, are required urgently and should be targeted toward men in particular. Dove Medical Press 2018-05-09 /pmc/articles/PMC5951132/ /pubmed/29780262 http://dx.doi.org/10.2147/CLEP.S151246 Text en © 2018 Robsahm et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Robsahm, Trude Eid
Helsing, Per
Nilssen, Yngvar
Vos, Linda
Rizvi, Syed Mohammad H
Akslen, Lars A
Veierød, Marit B
High mortality due to cutaneous melanoma in Norway: a study of prognostic factors in a nationwide cancer registry
title High mortality due to cutaneous melanoma in Norway: a study of prognostic factors in a nationwide cancer registry
title_full High mortality due to cutaneous melanoma in Norway: a study of prognostic factors in a nationwide cancer registry
title_fullStr High mortality due to cutaneous melanoma in Norway: a study of prognostic factors in a nationwide cancer registry
title_full_unstemmed High mortality due to cutaneous melanoma in Norway: a study of prognostic factors in a nationwide cancer registry
title_short High mortality due to cutaneous melanoma in Norway: a study of prognostic factors in a nationwide cancer registry
title_sort high mortality due to cutaneous melanoma in norway: a study of prognostic factors in a nationwide cancer registry
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5951132/
https://www.ncbi.nlm.nih.gov/pubmed/29780262
http://dx.doi.org/10.2147/CLEP.S151246
work_keys_str_mv AT robsahmtrudeeid highmortalityduetocutaneousmelanomainnorwayastudyofprognosticfactorsinanationwidecancerregistry
AT helsingper highmortalityduetocutaneousmelanomainnorwayastudyofprognosticfactorsinanationwidecancerregistry
AT nilssenyngvar highmortalityduetocutaneousmelanomainnorwayastudyofprognosticfactorsinanationwidecancerregistry
AT voslinda highmortalityduetocutaneousmelanomainnorwayastudyofprognosticfactorsinanationwidecancerregistry
AT rizvisyedmohammadh highmortalityduetocutaneousmelanomainnorwayastudyofprognosticfactorsinanationwidecancerregistry
AT akslenlarsa highmortalityduetocutaneousmelanomainnorwayastudyofprognosticfactorsinanationwidecancerregistry
AT veierødmaritb highmortalityduetocutaneousmelanomainnorwayastudyofprognosticfactorsinanationwidecancerregistry